The historic convention will see close to 400 delegates from the cardiology and healthcare industry gather for the first time in Auckland. Photo Credit: Adobe Stock/rudi1976
Tāmaki Makaurau Auckland’s strong bioengineering knowledge has won the Computing in Cardiology (CinC) scientific conference for 2027. This will be the first time the conference will be held in Australasia, and the third time it has taken place in the Asia Pacific region in 50 years.
Taking place in in September 2027 at the University of Auckland’s Owen G Glen Building, CinC will be expected to attract 350 delegates and deliver an economic impact of NZ$925,000 (US$556,304) to Auckland.
The bid for the event was led by Associate Professor Jichao Zhao from the Auckland Bioengineering Institute at the University of Auckland, with support from Auckland Convention Bureau (ACB) – which is a division of Tātaki Auckland Unlimited – and Tourism New Zealand Business Events.
“We’re delighted to have secured the CinC scientific conference in 2027,” said Ken Pereira, head of ACB. “Tāmaki Makaurau Auckland offers world-class innovation and capability in the bioengineering sector, so to bring delegates to our city is a valuable opportunity for discussion, advancing research opportunities and to make new connections.”
CinC will focus on computing in clinical cardiology and cardiovascular physiology to improve understanding, diagnosis and treatment of heart disease, providing a forum for cutting-edge developments at the intersection of clinical practice, cardiac electrophysiology and physiology, engineering, and fundamental research, including the growing role of artificial intelligence in diagnostic support.
Penelope Ryan, global manager business events at Tourism New Zealand, said: “By winning this conference, New Zealand will welcome an influx of international visitors in September, one of New Zealand’s off-peak months, and have a platform to showcase its research and innovation on a global stage.”